Flagship Pioneering’s Denali Therapeutics DNLI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-1,364,516
| Closed | -$28M | – | 7 |
|
|
2024
Q1 | $28M | Sell |
1,364,516
-955,452
| -41% | -$19.6M | 1.84% | 5 |
|
|
2023
Q4 | $49.8M | Sell |
2,319,968
-300,000
| -11% | -$6.44M | 3.76% | 5 |
|
|
2023
Q3 | $54M | Hold |
2,619,968
| – | – | 3.92% | 6 |
|
|
2023
Q2 | $77.3M | Hold |
2,619,968
| – | – | 3.45% | 6 |
|
|
2023
Q1 | $60.4M | Hold |
2,619,968
| – | – | 2.35% | 6 |
|
|
2022
Q4 | $72.9M | Hold |
2,619,968
| – | – | 2.33% | 7 |
|
|
2022
Q3 | $80.4M | Hold |
2,619,968
| – | – | 3.38% | 7 |
|
|
2022
Q2 | $77.1M | Hold |
2,619,968
| – | – | 2.9% | 6 |
|
|
2022
Q1 | $84.3M | Hold |
2,619,968
| – | – | 1.98% | 7 |
|
|
2021
Q4 | $117M | Sell |
2,619,968
-110,295
| -4% | -$4.92M | 1.81% | 8 |
|
|
2021
Q3 | $138M | Hold |
2,730,263
| – | – | 1.44% | 7 |
|
|
2021
Q2 | $214M | Hold |
2,730,263
| – | – | 2.74% | 6 |
|
|
2021
Q1 | $156M | Hold |
2,730,263
| – | – | 2.5% | 9 |
|
|
2020
Q4 | $229M | Sell |
2,730,263
-3,250,000
| -54% | -$272M | 4.16% | 7 |
|
|
2020
Q3 | $214M | Sell |
5,980,263
-2,000,000
| -25% | -$71.7M | 5.92% | 4 |
|
|
2020
Q2 | $193M | Hold |
7,980,263
| – | – | 5.61% | 3 |
|
|
2020
Q1 | $140M | Hold |
7,980,263
| – | – | 6.55% | 3 |
|
|
2019
Q4 | $139M | Sell |
7,980,263
-25,484
| -0.3% | -$444K | 7.77% | 3 |
|
|
2019
Q3 | $123M | Hold |
8,005,747
| – | – | 6.71% | 4 |
|
|
2019
Q2 | $166M | Hold |
8,005,747
| – | – | 7.19% | 4 |
|
|
2019
Q1 | $186M | Sell |
8,005,747
-913,002
| -10% | -$21.2M | 7.04% | 4 |
|
|
2018
Q4 | $184M | Hold |
8,918,749
| – | – | 9% | 4 |
|
|
2018
Q3 | $194M | Hold |
8,918,749
| – | – | 12.82% | 3 |
|
|
2018
Q2 | $136M | Hold |
8,918,749
| – | – | 26.05% | 2 |
|
|
2018
Q1 | $176M | Hold |
8,918,749
| – | – | 50.92% | 1 |
|
|
2017
Q4 | $139M | Buy |
+8,918,749
| New | +$139M | 35.37% | 1 |
|